(Q50881857)

24 March 2018

title

Cost-effectiveness of cognitive self-therapy in patients with depression and anxiety disorders. (English)

1 reference

24 March 2018

author name string

Stant AD

1

1 reference

24 March 2018

Ten Vergert EM

2

1 reference

24 March 2018

den Boer PC

3

1 reference

24 March 2018

Wiersma D

4

1 reference

24 March 2018

language of work or name

English

0 references

publication date

13 November 2007

1 reference

24 March 2018

Acta Psychiatrica Scandinavica

published in

1 reference

24 March 2018

volume

117

1 reference

24 March 2018

issue

1

1 reference

24 March 2018

page(s)

57-66

1 reference

24 March 2018

The need for psychiatric treatment in the general population: the Camberwell Needs for Care Survey

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Evidence of cost-effective treatments for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Health care costs associated with depressive and anxiety disorders in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Economic costs of minor depression: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

The friction cost method for measuring indirect costs of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Cost‐effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

The CE plane: a graphic representation of cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Costs, effects and C/E-ratios alongside a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Economic evaluation and clinical trials: size matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Missing... presumed at random: cost-analysis of incomplete data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01122.X

10.1111/J.1600-0447.2007.01122.X

21 January 2018

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018